US FDA refuses to approve first MDMA-based treatment for PTSD
The U.S. FDA has refused to approve a mind-altering MDMA-based therapy for patients with post-traumatic stress disorder, saying it cannot be approved based on the data submitted, developer Lykos Therapeutics said.
ПОПУЛЯРНЫЕ ПОСТЫ
Poland prepares for peaking floods
Сентябрь 20, 2024
Italy evacuates thousands as Boris hits the north
Сентябрь 20, 2024
China and the US race to tame nuclear fusion for clean energy
Сентябрь 20, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ